Forum: Can Singapore take part in motor neurone disease drug trial?

According to the Motor Neurone Disease Association Singapore, motor neurone disease (MND) affects up to 500 adults in Singapore at any one time.

The disease kills a third of people within a year and more than half within two years of diagnosis. Every year, 30 to 50 new cases are diagnosed.

I was diagnosed with MND this year and prescribed Riluzole, a drug that does not cure MND but purportedly slows down its progression.

Recently, I came across a report about a breakthrough drug called Ellorarxine that shows potential in tackling the underlying cause of MND.

I read further that the drug is entering human trials. I wonder if the relevant authorities here can collaborate with the drug-maker for participation in the trials to potentially benefit MND patients here.

Stanley Ong